会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • NOVEL INJECTABLE COMPOSITIONS AND PROCESS OF PREPARATION THEREOF
    • 新型注射剂组合物及其制备方法
    • WO2006126214A2
    • 2006-11-30
    • PCT/IN2006/000177
    • 2006-05-25
    • PANACEA BIOTEC LTD.JAIN, RajeshJINDAL, Kour, ChandSINGH, SukhjeetBOLDHANE, Sanjay
    • JAIN, RajeshJINDAL, Kour, ChandSINGH, SukhjeetBOLDHANE, Sanjay
    • A61K9/08
    • A61K47/183A61K9/0019A61K31/405A61K47/10
    • Novel and highly stable injectable pharmaceutical compositions comprising at least one cyclooxygenase-II enzyme (COX-II) inhibitor or non-steroidal anti-inflammatory drug (NSAID) or .COX/LOX inhibitor, or its tautomeric forms, analogues, isomers, polymorphs, solvates, prodrugs or salts thereof as active ingredient suitable for parenteral administration preferably by intramuscular (IM) or intravenous (IV) route; process of preparing such compositions and therapeutic methods of using such compositions are provided. The analgesic and anti-inflammatory injectable compositions of the present invention are very useful in mammals particularly in humans for the treatment of acute painful conditions like one or more of post-operative trauma, pain associated with cancer, sports injuries, migraine headache, neurological pain and pain associated with sciatica and spondylitis, and the like, and/or chronic painful conditions, and/or a variety of painful and inflammatory conditions like postoperative pain, primary dysmenorrhea and painful osteoarthritis, and/or other associated disorders such as inflammation, fever, allergy, or the like.
    • 包含至少一种环氧合酶II酶(COX-II)抑制剂或非甾体抗炎药(NSAID)或.COX / LOX抑制剂或其互变异构形式,类似物,异构体,多晶型物, 溶剂合物,前药或其盐作为适合肠胃外给药的活性成分,优选通过肌内(IM)或静脉内(IV)途径; 提供了制备这种组合物的方法和使用这种组合物的治疗方法。 本发明的镇痛和抗炎可注射组合物在哺乳动物,特别是人类中非常有用,用于治疗急性疼痛病症,如手术后创伤,与癌症相关的疼痛,运动损伤,偏头痛,神经痛 和与坐骨神经痛和脊椎炎相关的疼痛等,和/或慢性疼痛病症,和/或各种疼痛和炎症状况,如手术后疼痛,原发性痛经和疼痛性骨关节炎,和/或其他相关疾病如炎症,发热 ,过敏等。
    • 6. 发明申请
    • CONTROLLED RELEASE FORMULATION OF COATED MICROPARTICLES
    • 控制释放配方的包装微生物
    • WO2008122993A1
    • 2008-10-16
    • PCT/IN2008/000232
    • 2008-04-08
    • PANACEA BIOTEC LIMITEDJAIN, RajeshJINDAL, Kour ChandBOLDHANE, Sanjay
    • JAIN, RajeshJINDAL, Kour ChandBOLDHANE, Sanjay
    • A61K9/16A61K9/50A61K47/34A61K47/38
    • A61K9/5073A61K9/5026A61K9/5042
    • Controlled release compositions comprising microparticles which comprise a core and at least one coat, wherein the core comprises at least one active agent(s), optionally at least one water soluble polymer(s) and optionally one or more pharmaceutically acceptable excipient(s); and at least one coat comprising at least one pH independent polymer(s) along with one or more pharmaceutically acceptable excipient(s) are provided. Preferably the controlled release pharmaceutical compositions comprise microparticles along with at least one in-situ gelling agent(s), at least one cross-linking agent(s) and optionally one or more pharmaceutically acceptable excipient(s), wherein the said compositions are formulated as oral reconstitutable pharmaceutical controlled release suspensions, which can be reconstituted using a suitable reconstituting medium such as water. Further, this invention provides process of preparation of such compositions and method of using them.
    • 包含微粒的控制释放组合物包含核心和至少一个涂层,其中所述核心包含至少一种活性剂,任选的至少一种水溶性聚合物和任选的一种或多种药学上可接受的赋形剂; 并且提供至少一种包含至少一种不依赖于pH的聚合物以及一种或多种药学上可接受的赋形剂的涂层。 优选地,控释药物组合物包含微粒以及至少一种原位胶凝剂,至少一种交联剂和任选的一种或多种药学上可接受的赋形剂,其中所述组合物被配制 作为口服可重组的药物控制释放悬浮液,其可以使用合适的重构培养基如水重构。 此外,本发明提供了这种组合物的制备方法和使用它们的方法。